Consistent with non-small cell lung cancer (NSCLC) cells, TCZ decreased cell proliferation and induced the accumulation of sub-G1 phase in the cell cycle as well as possibly activating the NFκB pathway (Kim et al., 2015). Here, NFKB1 is linked to non-small cell lung carcinoma.